These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34218166)

  • 1. The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Hendriks PM; van Thor MCJ; Wapenaar M; Chandoesing P; van den Toorn LM; van den Bosch AE; Post MC; Boomars KA
    Respir Med; 2021 Sep; 186():106525. PubMed ID: 34218166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
    Berlier C; Schwarz EI; Saxer S; Lichtblau M; Ulrich S
    Lung; 2019 Jun; 197(3):353-360. PubMed ID: 30963265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counting Steps: A New Way to Monitor Patients with Pulmonary Arterial Hypertension.
    Sehgal S; Chowdhury A; Rabih F; Gadre A; Park MM; Li M; Wang X; Highland KB;
    Lung; 2019 Aug; 197(4):501-508. PubMed ID: 31144016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life is Related to Haemodynamics in Precapillary Pulmonary Hypertension.
    Arvanitaki A; Mouratoglou SA; Evangeliou A; Grosomanidis V; Hadjimiltiades S; Skoura L; Feloukidis C; Farmakis D; Karvounis H; Giannakoulas G
    Heart Lung Circ; 2020 Jan; 29(1):142-148. PubMed ID: 30686644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    McCabe C; Bennett M; Doughty N; MacKenzie Ross R; Sharples L; Pepke-Zaba J
    Chest; 2013 Aug; 144(2):522-530. PubMed ID: 23430021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
    Newnham M; Bunclark K; Abraham N; Ali S; Amaral-Almeida L; Cannon JE; Doughty N; Ng C; Ponnaberanam A; Sheares K; Speed N; Taboada D; Toshner M; Tsui S; Jenkins DP; Pepke-Zaba J
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32513780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.
    Wronski SL; Mordin M; Kelley K; Anguiano RH; Classi P; Shen E; Manaker S
    Lung; 2020 Feb; 198(1):65-86. PubMed ID: 31722043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience.
    Hoole SP; Coghlan JG; Cannon JE; Taboada D; Toshner M; Sheares K; Fletcher AJ; Martinez G; Ruggiero A; Screaton N; Jenkins D; Pepke-Zaba J
    Open Heart; 2020; 7(1):e001144. PubMed ID: 32180986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?
    Martínez Meñaca A; Blanco Vich I; López Meseguer M; López Reyes R; Bedate Díaz P; Elías Hernández T; Fernández-Cuesta Peñafiel I; Fernández G; Álvez Liste A; Escribano Subías P
    Adv Ther; 2021 Apr; 38(4):1860-1875. PubMed ID: 33675523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.
    Jin Q; Luo Q; Yang T; Zeng Q; Yu X; Yan L; Zhang Y; Zhao Q; Ma X; An C; Xiong C; Zhao Z; Liu Z
    Respir Res; 2019 Nov; 20(1):250. PubMed ID: 31703589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function.
    Spiesshoefer J; Herkenrath S; Mohr M; Randerath W; Tuleta I; Diller GP; Emdin M; Young P; Henke C; Florian AR; Yilmaz A; Boentert M; Giannoni A
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427479
    [No Abstract]   [Full Text] [Related]  

  • 12. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
    Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
    Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire.
    Reis A; Twiss J; Vicente M; Gonçalves F; Carvalho L; Meireles J; Melo A; McKenna SP; Almeida L
    Health Qual Life Outcomes; 2016 Jul; 14(1):110. PubMed ID: 27460644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension.
    Suntharalingam J; Goldsmith K; Toshner M; Doughty N; Sheares KK; Hughes R; Jenkins D; Pepke-Zaba J
    Respir Med; 2007 Nov; 101(11):2254-62. PubMed ID: 17706409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-cultural adaptation of the Cambridge Pulmonary Hypertension Outcome Review for use in patients with pulmonary hypertension in Colombia.
    Villaquirán C; Moreno S; Dueñas R; Acuña P; Lutz JR; Wilburn J; Heaney A
    J Bras Pneumol; 2019 Jul; 45(6):e20180332. PubMed ID: 31365733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impression life with pulmonary hypertension: clinically relevant characteristics and quality of life among patients in Gansu, China.
    Zhang J; Wen Y; Yin Y; Zhang Y; Zhang R; Zhang X; Ye J; Feng Y; Meng H
    Ther Adv Respir Dis; 2024; 18():17534666241246428. PubMed ID: 38676370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
    Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
    Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in health-related quality of life at early follow-up in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Ivarsson B; Johansson A; Kjellström B
    Pulm Circ; 2024 Jan; 14(1):e12349. PubMed ID: 38420145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension.
    Bunclark K; Doughty N; Michael A; Abraham N; Ali S; Cannon JE; Sheares K; Speed N; Taboada D; Toshner M; Pepke-Zaba J
    Pulm Circ; 2021; 11(2):2045894021995055. PubMed ID: 34104417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.